| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |